• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Lonza - Articles and news items

Lonza to Hold Free Webinar on LIMS and MODA-EM™ Solution – A Comprehensive Solution for Pharmaceutical Manufacturing Quality Control

Supplier news / 20 October 2016 / Lonza

Lonza will hold a free 60-minute webinar on 2 November 2016 titled “LIMS and MODA-EM™ Solution – A Comprehensive Solution for Pharmaceutical Manufacturing Quality Control”…

An interview with Lonza’s Minh Hong

Supplier news, Videos / 18 May 2016 / Kaynat Choudhury, Multimedia Content Manager

European Pharmaceutical Review’s Editor interviews Lonza’s Minh Hong to find out more about the L7…


UCB secures multimillion pound funding boost from UK Government

Industry news / 30 March 2015 / Victoria White

UCB has announced that its joint bid with five other organisations has secured a £6.2 million grant to support the development of novel biologic treatments…

Takeda & TiGenix announce Perianal Fistulas trial treatment results in patients with Crohn's disease

TiGenix and Lonza sign agreement for the manufacture of stem cell-based treatment of complex perianal fistulas in Crohn’s disease

Supplier news / 13 February 2015 / TiGenix

Lonza, a global leader in biological and cell therapy manufacturing and TiGenix, an advanced biopharmaceutical company focused on developing and commercialising novel therapeutics from allogeneic expanded adipose-derived stem cells (eASCs) in inflammatory and autoimmune diseases, announced today an agreement for the supply of TiGenix’s eASC product, Cx601.  Under the agreement, Lonza will manufacture material for […]


Lonza Group Ltd. and CAMO Software AS have entered into an agreement to deliver a PAT software solution to the Lonza Visp site

Supplier news / 5 November 2014 / CAMO Software

CAMO Software, leaders in multivariate data analysis software, and Lonza Group, a leading supplier to the pharma, biotech and specialty ingredients markets, have entered into an agreement where CAMO Software will deliver a PAT software solution for collecting, handling, storing, monitoring and modeling of PAT data…

BMS and Lonza expand biologics manufacturing agreement

Bristol-Myers Squibb and Lonza expand biologics manufacturing agreement

Industry news / 31 October 2014 / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company and Lonza today announced a multi-year expansion of their existing biologics manufacturing agreement. The contract expansion will include the production of commercial quantities of a second Bristol-Myers Squibb biologic medicine at Lonza’s mammalian manufacturing facility in Portsmouth, New Hampshire…

Don Paul Kovarcik, Business Development Manager, Lonza

Lonza interviewed at the ISSCR Annual Meeting 2014

News, Supplier news, Videos / 6 August 2014 / Freddy White, European Pharmaceutical Review

Freddy White speaks with Don Paul Kovarcik, Business Development Manager, Lonza at the ISSCR Annual Meeting 2014…

Lonza L7

Stem cells: from bench to drug development

Supplier news / 6 August 2014 / Don Paul Kovarcik, Lonza Walkersville, Inc.

Working in stem cell research can be both immensely rewarding and notoriously difficult. Lonza’s Don Paul Kovarik discusses the challenge of translating new advances in stem cell biology into viable, impactful therapies for patients…

Lonza and BioWa sign license agreements with Pfizer, Inc.

News, Supplier news / 30 July 2013 / Lonza

BioWa, Inc. and Lonza have entered into research agreements with Pfizer Inc. allowing the use of the POTELLIGENT® CHOK1SV Cell Line in the research and development of multiple proprietary antibodies in Pfizer’s pipeline…

Lonza launches 2013-2014 BioResearch Catalog

News, Supplier news / 14 May 2013 / Lonza

Diabetes prevention has become a key focus area for the drug development market…

Join Lonza’s March webinar on endotoxin detection methods

News, Supplier news / 26 February 2013 / Lonza

Lonza is hosting a free, 60-minute webinar entitled “Endotoxin Detection – Which Method Is Best for Me” at two different dates and times…

FDA allows Mycoplasma release testing of a biopharmaceutical product using MycoTOOL®

News, Supplier news / 29 January 2013 / Lonza

“Mycoplasma contamination represents a significant issue…”


Webinar: Understanding ISO Standards: ISO 14644-2:2015 Cleanroom MonitoringWATCH NOW
+ +